Literature DB >> 7946812

Inotropic agents for heart failure: what if digoxin increases mortality?

W J Remme1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7946812      PMCID： PMC1025601          DOI： 10.1136/hrt.72.3_suppl.s92

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  61 in total

1.  STUDIES ON DIGITALIS. X. EFFECTS OF OUABAIN ON FOREARM VASCULAR RESISTANCE AND VENOUS TONE IN NORMAL SUBJECTS AND IN PATIENTS IN HEART FAILURE.

Authors:  D T MASON; E BRAUNWALD
Journal:  J Clin Invest       Date:  1964-03       Impact factor: 14.808

2.  Effect of a digitalis drug on ventricular premature beats.

Authors:  B Lown; T B Graboys; P J Podrid; B H Cohen; M B Stockman; C E Gaughan
Journal:  N Engl J Med       Date:  1977-02-10       Impact factor: 91.245

3.  Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients without heart failure.

Authors:  H DeMots; S H Rahimtoola; J H McAnulty; G A Porter
Journal:  Am J Cardiol       Date:  1978-01       Impact factor: 2.778

4.  Calcium transients in mammalian ventricular muscle.

Authors:  D G Allen; S Kurihara
Journal:  Eur Heart J       Date:  1980       Impact factor: 29.983

5.  The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytes.

Authors:  F W Busch; A Tillmann; E W Becker; M Owsianowski; P A Berg
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.

Authors:  B F Uretsky; J B Young; F E Shahidi; L G Yellen; M C Harrison; M K Jolly
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

7.  Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy.

Authors:  F L Anderson; J D Port; B B Reid; G Hanson; A C Kralios; R E Hershberger; M R Bristow
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

8.  Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.

Authors:  A M Feldman; M R Bristow; W W Parmley; P E Carson; C J Pepine; E M Gilbert; J E Strobeck; G H Hendrix; E R Powers; R P Bain
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245

9.  Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).

Authors:  D J van Veldhuisen; A J Man in 't Veld; P H Dunselman; D J Lok; H J Dohmen; J C Poortermans; A J Withagen; W H Pasteuning; J Brouwer; K I Lie
Journal:  J Am Coll Cardiol       Date:  1993-11-15       Impact factor: 24.094

10.  Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.

Authors:  M Packer; M Gheorghiade; J B Young; P J Costantini; K F Adams; R J Cody; L K Smith; L Van Voorhees; L A Gourley; M K Jolly
Journal:  N Engl J Med       Date:  1993-07-01       Impact factor: 91.245
View more
  2 in total

1.  Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations.

Authors:  Ali Ahmed
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-03       Impact factor: 6.053

2.  Effects of milrinone on serum IL-6, TNF-α, Cys-C and cardiac functions of patients with chronic heart failure.

Authors:  Tingguo Shao; Yuqing Zhang; Rubo Tang; Hai Zhang; Quanzheng Wang; Ying Yang; Tongxiang Liu
Journal:  Exp Ther Med       Date:  2018-08-31       Impact factor: 2.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.